Safely Treat COVID with Metformin – Peer Reviewed Studies Prove

by Nov 21, 2023Covid Treatment

Did you know that metformin can be used to treat COVID? It is truly “safe and effective.”

Carolyn Bramante did multiple studies showing metformin works to treat COVID. It was published in 2 peer-reviewed journals. Yet, no COVID treatment guidelines anywhere in the US recommend it’s use.

Phase 3 trial on Metformin shows it is highly effective against COVID. It is much safer and more effective than the COVID vaccines.

Executive summary

If I haven’t yet convinced you yet just how corrupt the medical community is, this one should do it.

Metformin is a very safe drug which has been proven in multiple randomized trials to reduce hospitalization and death and reduce the chance of long-haul COVID. It is a very safe drug. The studies were published in peer-reviewed journals.

Guess how many clinical treatment guidelines in the US have added metformin to their protocols?

If you guess zero, you are right.

Here are the studies

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 (NEJM)
Phase 3 DB-RCT showed the adjusted odds ratio for hospitalization or death was 0.47 (95% CI, 0.20 to 1.11) with metformin. So it’s around a 53% risk reduction which is way better (and safer) than the COVID vaccines.

Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial (The Lancet)
When metformin was started within 3 days of symptom onset, the HR for long-COVID was 0·37 (95% CI 0·15–0·95), i.e., a 63% risk reduction.